作者:Julia Senkiv、Nataliya Finiuk、Danylo Kaminskyy、Dmytro Havrylyuk、Magdalena Wojtyra、Iryna Kril、Andrzej Gzella、Rostyslav Stoika、Roman Lesyk
DOI:10.1016/j.ejmech.2016.03.089
日期:2016.7
structure and purity of compounds were confirmed by analytical and spectral data including X-ray analysis. Target compounds were screened for their anticancer activity and selective antileukemic action was confirmed. 5-[5-(2-Hydroxyphenyl)-3-phenyl-4,5-dihydropyrazol-1-ylmethylene]-3-(3-acetoxyphenyl)-2-thioxothiazolidin-4-one (compound 1) was selected as most active agent against HL-60 and HL-60/ADR
本文介绍了以烯胺基连接吡唑核心的5-ene-4-thiazolidinone衍生物的合成方法。化合物的结构和纯度通过包括X射线分析在内的分析和光谱数据进行了确认。筛选目标化合物的抗癌活性,并确认了选择性抗白血病作用。选择5- [5-(2-羟基苯基)-3-苯基-4,5-二氢吡唑-1-基亚甲基] -3-(3-乙酰氧基苯基)-2-硫代噻唑烷-4-(化合物1)作为最有效的化合物抗HL-60和HL-60 / ADR细胞系的药物; IC 50 = 118 nM / HL-60,对伪正常细胞毒性低。线粒体依赖性细胞凋亡被认为是1作用的主要模式。另外,化合物的作用诱发了G 0 / G 1。 抑制所处理的细胞并引起细胞分裂的抑制,并且与ROS产生的活化有关。